Atlas Trials

Comparing Oral Lumbrokinase DLBS1033 and Betahistine Mesylate in Benign Paroxysmal Positional Vertigo

Clinical trial NCT07075289 · COMPLETED

Trial details

NCT number
NCT07075289
Sponsor
Universitas Sebelas Maret
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Benign Paroxysmal Positional Vertigo (Disorder)
Start date
2024-04-01
Primary completion
2024-08-31
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.